Blueprint Medicines (NASDAQ:BPMC) reported quarterly losses of $(1.86) per share which met the analyst consensus estimate. This is a 18.42 percent increase over losses of $(2.28) per share from the same period last year. The company reported quarterly sales of $27.30 million which beat the analyst consensus estimate of $19.01 million by 43.58 percent. This is a 227.16 percent increase over sales of $8.34 million the same period last year.
Recap: First Horizon Q1 Earnings
First Horizon (NYSE:FHN) reported its Q1 earnings results on Tuesday, April 19, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
First Horizon beat estimated earnings by 8.57%, reporting an EPS of $0.38 versus an estimate of $0.35.
